Utile Therapeutics Private Limited
About Utile Therapeutics Private Limited
Data last updated:
Utile Therapeutics Private Limited is a private limited company based in Ambala, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24299HR2019PTC081768.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Manish Kumar and Ankush.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Sukhbir Singh HUDA Sector – 34 Village Shahpur, Ambala, Haryana, India – 133004.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.61 Cr, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹12.84 Lakh (net margin 2.8%) and EBITDA of ₹27.29 Lakh (EBITDA margin 5.9%). Revenue has declined at a compounded annual rate (CAGR) of 24% over three years.
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Company details
Contact details
Utile Therapeutics Private Limited's registered office is in Ambala, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O Sukhbir Singh HUDA Sector – 34 Village Shahpur, Ambala, Haryana, India – 133004
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Utile Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Utile Therapeutics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Utile Therapeutics Private Limited, buy the company report.
Financials of Utile Therapeutics Private Limited
FY 2025 filings availableUtile Therapeutics Private Limited reported revenue of ₹4.61 Cr (down 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 24% over three years, including a 15% fall in the latest year. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹27.29 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.84 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.9% | ||||
| Net Profit Margin | 2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Utile Therapeutics Private Limited, buy the company report.
Board of directors of Utile Therapeutics Private Limited
Utile Therapeutics has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Kumar Also directs: Mediclove Formulations LLP, SBS Biotech Corporate Private Limited | Director | 01 Aug 2019 | 7 Years 3 Months | Current |
| Ankush Also directs: SBS Biotech Corporate Private Limited | Director | 23 Mar 2020 | 6 Years 7 Months | Current |
| Deepender Singh Also directs: SBS Biotech Corporate Private Limited | Director | 11 Dec 2020 | 5 Years 11 Months | Current |
Peer comparison
Utile Therapeutics Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Utile Therapeutics Private Limitedthis company | ₹4.61 Cr (FY 2025) | ₹12.84 Lakh | 2.8% | -15.0% | Ambala, Haryana, India | |
| Redcure Indian Pharma Private Limited | ₹4.61 Cr (FY 2025) | 1.0% | Jabalpur, Madhya Pradesh, India | |||
| Remedy Life Sciences India Private Limited | ₹4.6 Cr (FY 2025) | 2.0% | Hyderabad, Telangana, India | |||
| Royal Lifecure Private Limited | ₹4.58 Cr (FY 2025) | 1.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Utile Therapeutics Private Limited, buy the company report.
Auditor
Utile Therapeutics Private Limited is audited by O P MONGIA AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| O P MONGIA AND ASSOCIATES | FY 2023 | 085882 |
Shareholding
The shareholding of Utile Therapeutics Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Utile Therapeutics Private Limited, buy the company report.
Legal cases
Utile Therapeutics Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ludhiana, Punjab | Commercial suit | Filed against the company by State Through Drug Inspector | Pending |
To see the full case history of Utile Therapeutics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Utile Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Utile Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Utile Therapeutics Private Limited has 6 board changes on record since 2019: 4 appointments and 2 cessations. The latest: Naveen Sharma ceased to be Director on 23 Jul 2025.
Frequently asked questions
Utile Therapeutics is an active private limited company based in Ambala, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 August 2019 (7+ years old) and is registered under CIN U24299HR2019PTC081768.
Utile Therapeutics has 3 current directors:
- Manish Kumar - Director
- Ankush - Director
- Deepender Singh - Director
The latest financial statements of Utile Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Utile Therapeutics is U24299HR2019PTC081768. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Utile Therapeutics has 1 court case on record: 1 filed against it. 1 is pending.
Utile Therapeutics was incorporated on 01 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Utile Therapeutics by revenue are Redcure Indian Pharma Private Limited, Remedy Life Sciences India Private Limited, Royal Lifecure Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Naveen Sharma ceased to be Director on 23 Jul 2025. Ankush ceased to be Director on 19 Feb 2021. Deepender Singh was appointed as Director on 11 Dec 2020. Utile Therapeutics has 6 board changes on record in total.
The registered office of Utile Therapeutics is at CO Sukhbir Singh HUDA Sector – 34 Village Shahpur, Ambala, Haryana, India – 133004.
Utile Therapeutics operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Utile Therapeutics can be reached at its registered office: CO Sukhbir Singh HUDA Sector – 34 Village Shahpur, Ambala, Haryana, India – 133004.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
